Susan Turner - Innophos Holdings Vice President - Quality & Regulatory

President

Ms. Susan Turner is Vice President Quality and Regulatory of Innophos Holdings, Inc. Ms. Turner joined Stauffer Chemical in 1980 and has since held progressive roles in the areas of Engineering, Manufacturing, Maintenance, Project Management, and Human Resources. From 2009 to 2012, Ms. Turner served as Process Integration Lead for the ERP business systems redesign and then assumed leadership of the project post golive through the stabilization period. From 2005 to 2009, Ms. Turner served as Plant Manager of the Chicago Heights and Waterway manufacturing facilities. Prior to that, her experience included assignment in Mexico and France since 2012.
Age 60
Tenure 12 years
Phone609 495-2495
Webwww.innophos.com
Turner earned a B.S. in Mechanical Engineering from Utah State University.

Innophos Holdings Management Efficiency

Innophos Holdings' management efficiency ratios could be used to measure how well Innophos Holdings manages its routine affairs as well as how well it operates its assets and liabilities.
The company currently holds 399.86 M in liabilities with Debt to Equity (D/E) ratio of 118.3, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Innophos Holdings has a current ratio of 2.88, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Innophos Holdings until it has trouble settling it off, either with new capital or with free cash flow. So, Innophos Holdings' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Innophos Holdings sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Innophos to invest in growth at high rates of return. When we think about Innophos Holdings' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

PRESIDENT Age

Tara ComonteShake Shack
45
John LinkerJeld Wen Holding
45
John DingerJeld Wen Holding
50
Ronald PalmeseShake Shack
36
Peter MaxwellJeld Wen Holding
55
Tony MoralejoDine Brands Global
59
Steve ThompsonBoyd Gaming
55
Scott ViningJeld Wen Holding
61
Connie CollinsOne Group Hospitality
N/A
Michael KarkShake Shack
N/A
Daniel OlmoDine Brands Global
41
David GuernseyJeld Wen Holding
57
Peter FarmakisJeld Wen Holding
52
Bryan AdelDine Brands Global
57
Darren RebelezDine Brands Global
52
John CywinskiDine Brands Global
61
Timothy CravenJeld Wen Holding
56
Josh HirsbergBoyd Gaming
62
Anthony McDuffieBoyd Gaming
59
Brooks MallardJeld Wen Holding
50
Allison HallDine Brands Global
59
Innophos Holdings, Inc., together with its subsidiaries, produces specialty ingredients with applications in food, health, nutrition, and industrial markets. As of February 7, 2020, Innophos Holdings, Inc. operates as a subsidiary of Iris Parent LLC. Innophos Holdings operates under Specialty Chemicals classification in USA and is traded on NASDAQ. It employs 1485 people. Innophos Holdings (IPHS) is traded on NASDAQ Exchange in USA and employs 1,485 people.

Management Performance

Innophos Holdings Leadership Team

Elected by the shareholders, the Innophos Holdings' board of directors comprises two types of representatives: Innophos Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Innophos. The board's role is to monitor Innophos Holdings' management team and ensure that shareholders' interests are well served. Innophos Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Innophos Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
Randolph Gress, Chairman, CEO and Pres
Eugenia Erlij, Vice President - Marketing
Kim Mink, CEO and President and Director
Abraham Shabot, Vice President Director General, Innophos Latin America
James Zallie, Independent Director
Peter Thomas, Director
Jean Mainente, Chief Human Resource Officer, Senior Vice President
William Dunworth, Chief Accounting Officer, Vice President Corporate Controller
Amado Cavazos, Independent Director
Nicolas Meyrial, Vice President - Commercial Nutrition
William Farran, Sr. VP, General Counsel and Member of Proxy Committee
Mark Thurston, Vice President - Corporate Strategy and Worldwide Business Development
Mark Feuerbach, Sr. VP of Investor Relations, Treasury, Financial Planning and Analysis
Mark Santangelo, Senior Vice President - Manufacturing, Engineering and EH&S
Gary Cappeline, Lead Independent Director
Susan Turner, Vice President - Quality & Regulatory
Yasef Murat, Senior Vice President - Global Manufacturing
Hermanus Kieftenbeld, CFO, Senior Vice President
Linda Myrick, Independent Director
Amy Hartzell, Vice President - Supply Chain and Purchasing
Sherry Duff, Chief Marketing Officer, Vice President
Gail Holler, Vice President - Human Resources
Joshua Horenstein, Acting Chief Legal Officer and Corporate Secretary
Jane Hilk, Director
Louis Calvarin, Chief Risk Officer and Sr. VP of Strategy
Robert Sklans, Chief Human Resource Officer, Senior Vice President
Joseph Golowski, Sr. VP of Global Specialty Phosphates
Charles Brodheim, Vice President Corporate Controller
Karen Osar, Independent Director
John Steitz, Independent Director
Robert Zatta, Director

Innophos Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Innophos Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.
Note that the Innophos Holdings information on this page should be used as a complementary analysis to other Innophos Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Consideration for investing in Innophos Stock

If you are still planning to invest in Innophos Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Innophos Holdings' history and understand the potential risks before investing.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format